SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Left Ventricular Dysfunction - Pipeline Review, H2 2013 Research Report

[February 14, 2014]

Research and Markets: Left Ventricular Dysfunction - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/8b8qpq/left_ventricular) has announced the addition of the "Left Ventricular Dysfunction - Pipeline Review, H2 2013" report to their offering.

'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Dysfunction.

Scope

- A snapshot of the global therapeutic scenario for Left Ventricular Dysfunction.

- A review of the Left Ventricular Dysfunction products under development by companies and universities/research institutes based on information derived from company and industry-speific sources.


- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Left Ventricular Dysfunction pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Left Ventricular Dysfunction Overview

Therapeutics Development

Pipeline Products for Left Ventricular Dysfunction - Overview

Pipeline Products for Left Ventricular Dysfunction - Comparative Analysis

Late Stage Products

Clinical Stage Products

Early Stage Products

Assessment by Monotherapy Products

Drug Profiles

carvedilol CR - Drug Profile

carvedilol CR - Drug Profile

omecamtiv mecarbil - Drug Profile

bromocriptine - Drug Profile

CAP-1002 - Drug Profile

cimaglermin alfa - Drug Profile

CPI-003 - Drug Profile

DIOHF - Drug Profile

carvedilol CR - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Featured News & Press Releases

Companies Mentioned

Amgen Inc.

Acorda Therapeutics, Inc.

Innopharmax Inc.

RedHill Biopharma Ltd.

Capricor Therapeutics, Inc.

For more information visit http://www.researchandmarkets.com/research/8b8qpq/left_ventricular

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.